13F Pro

Hedge Funds Similar to Royalty Pharma Sub-Manager,

13F Portfolio OverlapQ1 2026Royalty Pharma Sub-Manager, portfolio →
Institutional-grade research for retail investors

Most similar hedge funds by 13F overlap

Royalty Pharma Sub-Manager, LLC is an institutional investor managing $173M across 4 U.S. equity positions as of Q1 2026. Based on the overlap of conviction holdings in their latest 13F filings, the hedge funds with portfolios most similar to Royalty Pharma Sub-Manager, are DAFNA, with shared positions in $CYTK, $BCAX, $BHVN, $BCRX. The full ranking of 1 similar funds is below.

#1DAFNA Capital Management LLCActive
Some overlap · 4 shared positions
$CYTK$BCAX$BHVN$BCRX
$440M
83 positions

Compare Royalty Pharma Sub-Manager,’s portfolio side by side

See the exact shared positions, conviction overlap, sector alignment, and where these funds diverge — and run the same analysis on any of 8,700+ institutions.

View Royalty Pharma Sub-Manager,’s holdings

Similarity is derived from each fund’s latest 13F-HR filing with the SEC. Funds are ranked by the overlap of distinctive conviction holdings; near-universal mega-cap positions are excluded so the ranking reflects shared strategy, not common index exposure. Data is informational only and not investment advice.